Other OTC - Delayed Quote • USD
Celyad Oncology SA (CLYYF)
At close: April 1 at 9:30 AM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
44.0000
--
--
5.0000
Cost of Revenue
44.0000
--
--
--
Gross Profit
--
--
--
5.0000
Operating Expense
8,803.0000
20,263.0000
26,909.0000
26,220.0000
Operating Income
-8,803.0000
-20,263.0000
-26,909.0000
-26,215.0000
Net Non Operating Interest Income Expense
-201.0000
-185.0000
-116.0000
-217.0000
Other Income Expense
--
-20,422.0000
523.0000
9,228.0000
Pretax Income
-30,554.0000
-40,870.0000
-26,502.0000
-17,204.0000
Tax Provision
65.0000
65.0000
10.0000
--
Net Income Common Stockholders
-30,619.0000
-40,935.0000
-26,512.0000
-17,204.0000
Diluted NI Available to Com Stockholders
-30,619.0000
-40,935.0000
-26,512.0000
-17,204.0000
Basic EPS
-1.36
-1.81
-1.70
-1.23
Diluted EPS
-1.36
-1.81
-1.70
-1.23
Basic Average Shares
22,558.4720
22,593.9560
15,604.0140
13,942.3440
Diluted Average Shares
22,558.4720
22,593.9560
15,604.0140
13,942.3440
Total Operating Income as Reported
-30,525.0000
-40,857.0000
-26,391.0000
-16,987.0000
Rent Expense Supplemental
--
109.0000
50.0000
87.0000
Total Expenses
8,847.0000
20,263.0000
26,909.0000
26,220.0000
Net Income from Continuing & Discontinued Operation
-30,619.0000
-40,935.0000
-26,512.0000
-17,204.0000
Normalized Income
-14,456.5000
-20,513.0000
-27,363.0000
-26,432.0000
Interest Income
-110.0000
12.0000
27.0000
217.0000
Interest Expense
91.0000
197.0000
255.0000
434.0000
Net Interest Income
-201.0000
-185.0000
-116.0000
-217.0000
EBIT
-30,463.0000
-40,673.0000
-26,247.0000
-16,770.0000
EBITDA
-30,463.0000
-39,233.0000
-24,727.0000
-14,938.0000
Reconciled Cost of Revenue
44.0000
--
--
--
Reconciled Depreciation
--
1,440.0000
1,520.0000
1,832.0000
Net Income from Continuing Operation Net Minority Interest
-30,619.0000
-40,935.0000
-26,512.0000
-17,204.0000
Total Unusual Items Excluding Goodwill
-21,550.0000
-20,422.0000
851.0000
9,228.0000
Total Unusual Items
-21,550.0000
-20,422.0000
851.0000
9,228.0000
Normalized EBITDA
-8,913.0000
-18,811.0000
-25,578.0000
-24,166.0000
Tax Rate for Calcs
0.0003
--
--
--
Tax Effect of Unusual Items
-5,387.5000
--
--
--
12/31/2020 - 1/15/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade